AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32677499 — intervention group
Group type: COMPARATOR
Intervention: Standard counseling group (standard verbal counseling)
Number of subjects: 83
Study 32677499 — intervention group
Group type: COMPARATOR
Intervention: Standard counseling group (among families without baseline knowledge)
Number of subjects: 83
Study 32677499 — intervention group
Group type: EXPERIMENTAL
Intervention: Video group (among families without baseline knowledge)
Number of subjects: 83
Study 35707522 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative Acupuncture and Moxibustion (iAM) treatment
Number of subjects: 592
Study 35707522 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (50 mg once a day)
Number of subjects: 592
Study 35707522 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 592
Study 35707522 — intervention group
Group type: EXPERIMENTAL
Intervention: Active/sham iAM treatment (three times per week)
Number of subjects: 592
Study 34283799 — intervention group
Group type: EXPERIMENTAL
Intervention: Classical music played during treatment
Number of subjects: 222
Study 34283799 — intervention group
Group type: COMPARATOR
Intervention: No music played during treatment
Number of subjects: 222
Study 32085706 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU+WASH
Number of subjects: 495
Study 32085706 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU+WASH+SUPPORT
Number of subjects: 495
Study 32085706 — intervention group
Group type: COMPARATOR
Intervention: TAU
Number of subjects: 495
Study 34196048 — intervention group
Group type: EXPERIMENTAL
Intervention: MFPSS programme plus routine care
Number of subjects: 42
Study 34196048 — intervention group
Group type: COMPARATOR
Intervention: Routine care only
Number of subjects: 42
Study 33779064 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol (300 mg daily)
Number of subjects: 99
Study 33779064 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study 33218524 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily aerobic walking exercise (DAWE)
Number of subjects: 54
Study 33218524 — intervention group
Group type: COMPARATOR
Intervention: Sedentary lifestyle (Control Group)
Number of subjects: 54
Study 36291940 — intervention group
Group type: EXPERIMENTAL
Intervention: US‐NAB with ROSE
Number of subjects: 136
Study 36291940 — intervention group
Group type: COMPARATOR
Intervention: US‐NAB without ROSE
Number of subjects: 136
Study 32166831 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (3 µg/kg intravenous bolus)
Number of subjects: 18
Study 32173808 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine (R) 2mg/kg with ropivacaine: 4.75 mg/ml in wound infiltration (WI)
Number of subjects: 100
Study 32173808 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine and Dexmedetomidine (RD) 2mg/kg of ropivacaine and 0.5 ug/kg of DEX
Number of subjects: 100
Study 32173808 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine (R)
Number of subjects: 100
Study 32173808 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine and Dexmedetomidine (RD)
Number of subjects: 100
Study 33435969 — intervention group
Group type: EXPERIMENTAL
Intervention: Single incentive for HbA1c reduction at 3 months (Group 1)
Number of subjects: 60
Study 33435969 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-part equal incentive for home testing of glucose and HbA1c reduction at 3 months (Group 2)
Number of subjects: 60
Study 33435969 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-part equal incentive for home testing, attendance of weekly telephone education classes, and HbA1c reduction at 3 months (Group 3)
Number of subjects: 60
Study 35927806 — intervention group
Group type: EXPERIMENTAL
Intervention: Active 10Hz rTMS (n=63)
Number of subjects: 109
Study 35927806 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (n=46)
Number of subjects: 109
Study 35927806 — intervention group
Group type: EXPERIMENTAL
Intervention: Active 10Hz rTMS (n=63) in CC homozygotes
Number of subjects: 109
Study 35927806 — intervention group
Group type: EXPERIMENTAL
Intervention: Active 10Hz rTMS (n=63) in T allele carriers
Number of subjects: 109
Study 32979880 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined screening programme including a risk‐assessment questionnaire and rapid tests for point‐of‐care diagnosis
Number of subjects: 7991
Study 32979880 — intervention group
Group type: COMPARATOR
Intervention: Educational intervention only (control)
Number of subjects: 7991
Study 32979880 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined screening programme
Number of subjects: 7991
Study 36082412 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 114
Study 36082412 — intervention group
Group type: EXPERIMENTAL
Intervention: Light Dark Therapy (LDT)
Number of subjects: 114
Study 36082412 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-Usual (TAU)
Number of subjects: 114
Study 34477119 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminiscence therapy
Number of subjects: 160
Study 34477119 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 160
Study 33002437 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant radiotherapy (64 Gy in 32 fractions)
Number of subjects: 333
Study 33002437 — intervention group
Group type: COMPARATOR
Intervention: Salvage radiotherapy (64 Gy in 32 fractions triggered by PSA of 0.20 ng/mL or more)
Number of subjects: 333
Study 35809658 — intervention group
Group type: EXPERIMENTAL
Intervention: IOL oriented vertically
Number of subjects: 163
Study 35809658 — intervention group
Group type: EXPERIMENTAL
Intervention: IOL oriented horizontally
Number of subjects: 163
Study 35809658 — intervention group
Group type: EXPERIMENTAL
Intervention: IOL oriented superonasally
Number of subjects: 163
Study 35809658 — intervention group
Group type: EXPERIMENTAL
Intervention: IOL oriented inferonasally
Number of subjects: 163
Study 35809658 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 163
Study 32609918 — intervention group
Group type: EXPERIMENTAL
Intervention: TMJ arthroscopy plus hyaluronic acid (HA)
Number of subjects: 51
Study 32609918 — intervention group
Group type: COMPARATOR
Intervention: TMJ arthroscopy
Number of subjects: 51
Study 32881903 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibromyalgia (FM) group
Number of subjects: 0
Study 32881903 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibromyalgia (FM) group with comorbidities (diabetes, hyperlipidemia, depression, Meniere’s disease)
Number of subjects: 0
Study 32881903 — intervention group
Group type: COMPARATOR
Intervention: Non-FM group
Number of subjects: 0
Study 35913793 — intervention group
Group type: EXPERIMENTAL
Intervention: Preprocedural anxiety (assessed using State‐Trait Anxiety Inventory for Children)
Number of subjects: 90
Study 34848508 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal high flow rhinothermy (rNHF) - 100% humidified air delivered at 35 L/min and 41°C for 2 hours daily for 5 days
Number of subjects: 170
Study 34848508 — intervention group
Group type: COMPARATOR
Intervention: Sham rhinothermy - 100% humidified air delivered at 10 L/min and 31°C for 10 min daily for 5 days
Number of subjects: 170
Study 34848508 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal high flow rhinothermy (rNHF)
Number of subjects: 170
Study 34848508 — intervention group
Group type: COMPARATOR
Intervention: Sham rhinothermy
Number of subjects: 170
Study 34587648 — intervention group
Group type: EXPERIMENTAL
Intervention: L-NMMA (NOS inhibitor)
Number of subjects: 14
Study 35792453 — intervention group
Group type: EXPERIMENTAL
Intervention: Head-of-bed elevation to 45°
Number of subjects: 20
Study 35792453 — intervention group
Group type: COMPARATOR
Intervention: No head-of-bed elevation
Number of subjects: 20
Study 35792453 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical algorithm with head-of-bed elevation
Number of subjects: 20
Study 35792453 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite ultrasound scale
Number of subjects: 20
Study 34142638 — intervention group
Group type: EXPERIMENTAL
Intervention: Tribulus terrestris 94mg, three times/day for 90 days (TT3)
Number of subjects: 104
Study 34142638 — intervention group
Group type: EXPERIMENTAL
Intervention: Tribulus terrestris 280mg once/day for 90 days (TT1)
Number of subjects: 104
Study 34142638 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 104
Study 32078891 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU + AE
Number of subjects: 40
Study 32078891 — intervention group
Group type: COMPARATOR
Intervention: TAU alone
Number of subjects: 40
Study 33962601 — intervention group
Group type: COMPARATOR
Intervention: Mild physical activity
Number of subjects: 245
Study 33962601 — intervention group
Group type: COMPARATOR
Intervention: Moderate and severe physical activity
Number of subjects: 245
Study 33962601 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher BMI and body fat mass (BFM)
Number of subjects: 245
Study 33962601 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower lean body mass (LBM) and soft lean mass (SLM)
Number of subjects: 245
Study 32276611 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro-AF group (n=221)
Number of subjects: 3763
Study 32276611 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=250)
Number of subjects: 3763
Study 33327985 — intervention group
Group type: EXPERIMENTAL
Intervention: Gloves
Number of subjects: 30
Study 33327985 — intervention group
Group type: EXPERIMENTAL
Intervention: Gloves plus gowns
Number of subjects: 30
Study 33327985 — intervention group
Group type: COMPARATOR
Intervention: No barrier
Number of subjects: 30
Study 33327985 — intervention group
Group type: EXPERIMENTAL
Intervention: Gloves plus gowns with hand hygiene
Number of subjects: 30
Study 32861569 — intervention group
Group type: EXPERIMENTAL
Intervention: IRE-FOLFIRINOX
Number of subjects: 52
Study 32861569 — intervention group
Group type: COMPARATOR
Intervention: FOLFIRINOX-only
Number of subjects: 52
Study 36063974 — intervention group
Group type: EXPERIMENTAL
Intervention: BoNT/A
Number of subjects: 88
Study 36063974 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study 33675264 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemp-based nutraceutical product (Gs Formula; GF) at 160 g/day (LO)
Number of subjects: 8
Study 33675264 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemp-based nutraceutical product (Gs Formula; GF) at 480 g/day (HI)
Number of subjects: 8
Study 33675264 — intervention group
Group type: COMPARATOR
Intervention: Hemp-based nutraceutical product (Gs Formula; GF) at 0 g/day (CON)
Number of subjects: 8
Study 32474979 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric calf-muscle exercises (tiptoes)
Number of subjects: 91
Study 32474979 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric calf-muscle exercises (dorsiflexed ankle position)
Number of subjects: 91
Study 32474979 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic calf-muscle exercises
Number of subjects: 91
Study 32474979 — intervention group
Group type: COMPARATOR
Intervention: Rest
Number of subjects: 91
Study 35761341 — intervention group
Group type: EXPERIMENTAL
Intervention: Indwelling pleural catheter (IPC)
Number of subjects: 158
Study 35761341 — intervention group
Group type: COMPARATOR
Intervention: Video-assisted thoracoscopic surgery (VATS) pleurodesis
Number of subjects: 158
Study 34082113 — intervention group
Group type: EXPERIMENTAL
Intervention: Flipped classroom
Number of subjects: 110
Study 34082113 — intervention group
Group type: EXPERIMENTAL
Intervention: Flipped classroom (exotropia)
Number of subjects: 110
Study 34082113 — intervention group
Group type: COMPARATOR
Intervention: Traditional classroom (esotropia)
Number of subjects: 110
Study 34082113 — intervention group
Group type: EXPERIMENTAL
Intervention: Flipped classroom (esotropia)
Number of subjects: 110
Study 34082113 — intervention group
Group type: COMPARATOR
Intervention: Traditional classroom (exotropia)
Number of subjects: 110
Study 32791704 — intervention group
Group type: EXPERIMENTAL
Intervention: Sogyeonghwalhyeol-tang (SGHH) alone
Number of subjects: 150
Study 32791704 — intervention group
Group type: EXPERIMENTAL
Intervention: Sogyeonghwalhyeol-tang (SGHH) with Chuna manual therapy (CMT)
Number of subjects: 150
Study 32791704 — intervention group
Group type: COMPARATOR
Intervention: Placebo with Chuna manual therapy (CMT)
Number of subjects: 150
Study 35167764 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (25,000 IU weekly)
Number of subjects: 90
Study 35167764 — intervention group
Group type: COMPARATOR
Intervention: Nothing (control group)
Number of subjects: 90
Study 34914293 — intervention group
Group type: EXPERIMENTAL
Intervention: NNN linkages-based standardized nursing language
Number of subjects: 96
Study 34914293 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing
Number of subjects: 96
Study 35586992 — intervention group
Group type: EXPERIMENTAL
Intervention: VPT-lecture combined with a VPT-laboratory (experimental group)
Number of subjects: 108
Study 35586992 — intervention group
Group type: COMPARATOR
Intervention: VPT lecture-only (control group)
Number of subjects: 108
Study 34274600 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 96
Study 34274600 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective Serotonin Reuptake Inhibitor (SSRI)
Number of subjects: 96
Study 32019428 — intervention group
Group type: EXPERIMENTAL
Intervention: aCPAP plus usual care
Number of subjects: 3062
Study 32019428 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual
Number of subjects: 3062
Study 35062907 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional intervention (one egg per day for 6 months)
Number of subjects: 600
Study 35062907 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent Grandi Byen intervention (responsive parenting, nutrition, WASH + one egg per day for 6 months)
Number of subjects: 600
Study 35062907 — intervention group
Group type: COMPARATOR
Intervention: Standard well-baby care
Number of subjects: 600
Study 34900185 — intervention group
Group type: EXPERIMENTAL
Intervention: Chrysanthemum extract 400 mg/day (200 mg/day, twice/day)
Number of subjects: 46
Study 34900185 — intervention group
Group type: COMPARATOR
Intervention: Standard stroke treatment
Number of subjects: 46
Study 36459070 — intervention group
Group type: EXPERIMENTAL
Intervention: Subtalar joint mobilization with movement (STJ MWM)
Number of subjects: 28
Study 36459070 — intervention group
Group type: COMPARATOR
Intervention: Control group (neurodevelopmental treatment and talocrural joint MWM)
Number of subjects: 28
Study 33615468 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol
Number of subjects: 88
Study 33615468 — intervention group
Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 88
Study 33267762 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal Dexamethasone implant (IVD) 0.7 mg, single dose
Number of subjects: 140
Study 33267762 — intervention group
Group type: COMPARATOR
Intervention: Intravitreal Ranibizumab injection (IVR) 0.3 mg, 3 doses (monthly)
Number of subjects: 140
Study 33267762 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal Dexamethasone implant (IVD)
Number of subjects: 140
Study 33267762 — intervention group
Group type: COMPARATOR
Intervention: Intravitreal Ranibizumab injection (IVR)
Number of subjects: 140
Study 35879205 — intervention group
Group type: COMPARATOR
Intervention: Slit-artreriotomy group
Number of subjects: 20
Study 34021118 — intervention group
Group type: EXPERIMENTAL
Intervention: Rd with clarithromycin (C-Rd)
Number of subjects: 286
Study 34021118 — intervention group
Group type: COMPARATOR
Intervention: Rd without clarithromycin (Rd)
Number of subjects: 286
Study 34021118 — intervention group
Group type: EXPERIMENTAL
Intervention: C-Rd
Number of subjects: 286
Study 34021118 — intervention group
Group type: COMPARATOR
Intervention: Rd
Number of subjects: 286
Study 33631355 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab (60 mg/6 months)
Number of subjects: 139
Study 33631355 — intervention group
Group type: COMPARATOR
Intervention: Alendronate (70 mg/week)
Number of subjects: 139
Study 33631355 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab
Number of subjects: 139
Study 33631355 — intervention group
Group type: COMPARATOR
Intervention: Alendronate
Number of subjects: 139
Study 33631355 — intervention group
Group type: COMPARATOR
Intervention: Denosumab and Alendronate
Number of subjects: 139
Study 32282491 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatherapy (lavender oil) inhalation administered half hour before sleep every day for a month.
Number of subjects: 59
Study 32282491 — intervention group
Group type: COMPARATOR
Intervention: No administration applied to the control group.
Number of subjects: 59
Study 35830078 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic-assisted thoracic surgery (RATS)
Number of subjects: 76
Study 35830078 — intervention group
Group type: COMPARATOR
Intervention: Video-assisted thoracic surgery (VATS)
Number of subjects: 76
Study 33908306 — intervention group
Group type: EXPERIMENTAL
Intervention: Hispanic families
Number of subjects: 0
Study 33908306 — intervention group
Group type: COMPARATOR
Intervention: Non-Hispanic families
Number of subjects: 0
Study 33908306 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in coping strategies
Number of subjects: 0
Study 32492157 — intervention group
Group type: EXPERIMENTAL
Intervention: Early prophylaxis
Number of subjects: 37
Study 32492157 — intervention group
Group type: COMPARATOR
Intervention: Delayed prophylaxis
Number of subjects: 37
Study 32492157 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylaxis
Number of subjects: 37
Study 33704366 — intervention group
Group type: EXPERIMENTAL
Intervention: itMatters intervention
Number of subjects: 3098
Study 33704366 — intervention group
Group type: EXPERIMENTAL
Intervention: SVP component
Number of subjects: 3098
Study 33049709 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol therapy
Number of subjects: 36
Study 33049709 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 36422204 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical dexamethasone (1 mg/mL)
Number of subjects: 90
Study 36422204 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical bromfenac (0.9 mg/mL)
Number of subjects: 90
Study 36422204 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 34555822 — intervention group
Group type: EXPERIMENTAL
Intervention: Active stimulation
Number of subjects: 59
Study 34555822 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 59
Study 32066489 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor (loading dose 180 mg, maintenance dose 90 mg bid)
Number of subjects: 100
Study 32066489 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel (loading dose 600 mg, maintenance dose 75 mg)
Number of subjects: 100
Study 32066489 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 100
Study 32066489 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 100
Study 35150621 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-cost behavioural intervention including folk performance, transect walk, community meeting, recognition banners, community wall painting, mothers’ meetings, household visits, and latrine repairs.
Number of subjects: 3723
Study 35150621 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 3723
Study 35150621 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-cost behavioural intervention.
Number of subjects: 3723
Study 34167675 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravascular lithotripsy (IVL)
Number of subjects: 306
Study 34167675 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous transluminal angioplasty (PTA)
Number of subjects: 306
Study 36146909 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention (informational handouts and videos about health effects of juice and SSBs)
Number of subjects: 144
Study 33915812 — intervention group
Group type: EXPERIMENTAL
Intervention: Technology-based intervention for self-management behaviors
Number of subjects: 0
Study 36281763 — intervention group
Group type: COMPARATOR
Intervention: Clinic-based care using best practices and face-to-face visits with physicians and medical assistants
Number of subjects: 3071
Study 36281763 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth care using best practices and home BP telemonitoring with home-based care coordinated by a clinical pharmacist or nurse practitioner
Number of subjects: 3071
Study 36281763 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth care
Number of subjects: 3071
Study 33655799 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly aerobic exercises associated with nutritional counseling
Number of subjects: 58
Study 33655799 — intervention group
Group type: COMPARATOR
Intervention: Usual care with nutritional counseling
Number of subjects: 58
Study 33936350 — intervention group
Group type: EXPERIMENTAL
Intervention: remifentanil/propofol (group P)
Number of subjects: 60
Study 33936350 — intervention group
Group type: COMPARATOR
Intervention: remifentanil/sevoflurane (group S)
Number of subjects: 60
Study 32271583 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultraviolet-Ozone (UVO) treatment applied to drug-coated balloons (DCBs) with urea-paclitaxel coating.
Number of subjects: 0
Study 32271583 — intervention group
Group type: COMPARATOR
Intervention: Standard drug-coated balloons (DCBs) without UVO treatment.
Number of subjects: 0
Study 35213106 — intervention group
Group type: EXPERIMENTAL
Intervention: Powered Endoscopic Turbinoplasty (PET)
Number of subjects: 50
Study 35213106 — intervention group
Group type: COMPARATOR
Intervention: Partial Inferior Turbinectomy (PIT)
Number of subjects: 50
Study 34215519 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized visual assessment (5-point bleeding score)
Number of subjects: 0
Study 34215519 — intervention group
Group type: COMPARATOR
Intervention: ROTEM® measurements
Number of subjects: 0
Study 33028395 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistent HPV16 infection
Number of subjects: 96
Study 33028395 — intervention group
Group type: COMPARATOR
Intervention: Transient HPV16 infection
Number of subjects: 96
Study 33028395 — intervention group
Group type: COMPARATOR
Intervention: HPV negative women
Number of subjects: 96
Study 36198841 — intervention group
Group type: EXPERIMENTAL
Intervention: Labels: lumbar sprain, non-specific low back pain, episode of back pain
Number of subjects: 1447